These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21061396)

  • 1. Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosis.
    Balashov KE; Aung LL; Vaknin-Dembinsky A; Dhib-Jalbut S; Weiner HL
    Ann Neurol; 2010 Dec; 68(6):899-906. PubMed ID: 21061396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta.
    Aung LL; Fitzgerald-Bocarsly P; Dhib-Jalbut S; Balashov K
    J Neuroimmunol; 2010 Sep; 226(1-2):158-64. PubMed ID: 20621365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
    Derkow K; Bauer JM; Hecker M; Paap BK; Thamilarasan M; Koczan D; Schott E; Deuschle K; Bellmann-Strobl J; Paul F; Zettl UK; Ruprecht K; Lehnardt S
    PLoS One; 2013; 8(8):e70626. PubMed ID: 23950974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells.
    Xu Y; Hu Y; Shi B; Zhang X; Wang J; Zhang Z; Shen F; Zhang Q; Sun S; Yuan Z
    Mol Immunol; 2009 Aug; 46(13):2640-6. PubMed ID: 19501403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
    Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
    Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta.
    Lande R; Gafa V; Serafini B; Giacomini E; Visconti A; Remoli ME; Severa M; Parmentier M; Ristori G; Salvetti M; Aloisi F; Coccia EM
    J Neuropathol Exp Neurol; 2008 May; 67(5):388-401. PubMed ID: 18431257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells.
    Chung NP; Matthews K; Klasse PJ; Sanders RW; Moore JP
    J Immunol; 2012 Dec; 189(11):5257-65. PubMed ID: 23100517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.
    Libri NA; Barker SJ; Rosenberg WM; Semper AE
    J Viral Hepat; 2009 May; 16(5):315-24. PubMed ID: 19243499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).
    Tao Y; Zhang X; Markovic-Plese S
    J Neuroimmunol; 2016 Sep; 298():181-8. PubMed ID: 27609294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
    Yu JE; Knight AK; Radigan L; Marron TU; Zhang L; Sanchez-Ramón S; Cunningham-Rundles C
    J Allergy Clin Immunol; 2009 Aug; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.
    Kuo CH; Hsieh CC; Kuo HF; Huang MY; Yang SN; Chen LC; Huang SK; Hung CH
    Allergy; 2013 Jul; 68(7):870-9. PubMed ID: 23738920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.
    Schroeder JT; Chichester KL; Bieneman AP
    J Allergy Clin Immunol; 2008 Feb; 121(2):486-91. PubMed ID: 18036648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9.
    Simmons DP; Canaday DH; Liu Y; Li Q; Huang A; Boom WH; Harding CV
    J Immunol; 2010 Aug; 185(4):2405-15. PubMed ID: 20660347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns.
    Hsiao HB; Chou AH; Lin SI; Chen IH; Lien SP; Liu CC; Chong P; Liu SJ
    J Virol; 2014 Oct; 88(20):11658-70. PubMed ID: 25078697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
    Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
    J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells.
    Talukder AH; Bao M; Kim TW; Facchinetti V; Hanabuchi S; Bover L; Zal T; Liu YJ
    Cell Res; 2012 Jul; 22(7):1129-39. PubMed ID: 22453241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting β2-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation.
    Kuo CH; Yang SN; Tsai YG; Hsieh CC; Liao WT; Chen LC; Lee MS; Kuo HF; Lin CH; Hung CH
    Pulm Pharmacol Ther; 2018 Feb; 48():37-45. PubMed ID: 28987803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands.
    Ju X; Zenke M; Hart DN; Clark GJ
    Blood; 2008 Aug; 112(4):1184-94. PubMed ID: 18535206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.